http://web.archive.org/web/20150218154330id_/http://www.dailymail.co.uk/news/article-2358217/GlaxoSmithKline-investigates-staff-bribed-doctors-China-prescribe-Botox-treatments.html

@entity0 said today it was investigating new allegations that its staff had used improper tactics to market @entity4 in @entity5 , but had so far found no evidence of bribery or corruption			1
the move follows a claim that @entity0 staff allegedly handed doctors cash and other rewards for prescribing @entity4 treatment , which the @entity16 group sells in @entity5 under an agreement with patent - holder @entity18			1
the latest allegations against @entity0 , which is already under investigation by @entity5 police for unspecified ' economic crimes ' , were first reported by the @entity24			2
did they bribe doctors ? @entity16 pharmaceutical company @entity0 is investigating new allegations that its staff had used improper tactics to market @entity4 in @entity5 the newspaper said internal documents and email showed @entity0 's @entity5 sales staff were also apparently instructed to use their personal email addresses to discuss marketing strategies related to @entity4			1
a @entity0 spokesman in @entity34 said the company believed the new allegations over @entity4 came from the same source who previously made claims over corruption in china - claims which @entity0 said earlier it had investigated and found to be without foundation			1
' nevertheless , we are investigating these new claims			1
however , our inquiries to date have found no evidence of bribery or corruption in relation to our sales and marketing of therapeutic @entity4 in @entity5 , ' the spokesman said			2
' @entity0 has some of the toughest compliance procedures in the sector			0
we are proud of our high standards and operate in accordance with them			0
' the @entity24 said emails and documents it had seen also discussed a marketing strategy for @entity4 that targeted 48 doctors and planned to reward them with either a percentage of the cash value of the prescription , or educational credits , based on the number of prescriptions the doctors made			0
claims : @entity0 staff allegedly handed doctors cash and other rewards for prescribing @entity4 treatment , which it sells under an agreement with patent - holder @entity18 ( file picture ) the strategy was called ' @entity78 ' after the @entity81 @entity80 sniper @entity79			1
' we have investigated the specific claim on the so - called @entity78 programme			0
our investigation has found that while the proposal did n't contain anything untoward , the programme was never implemented , ' the company spokesman said			0
@entity0 is responsible for therapeutic sales of @entity4 in @entity5 - for example , to treat facial spasms - rather than its use as a cosmetic treatment to remove wrinkles			0
the allegations come as police in the south - central @entity5 city of @entity99 investigate high - level @entity5 staff at @entity0 on suspicion of economic crimes			0
it is not clear if the @entity99 investigation is related to any of the allegations			0
@entity5 is an increasingly important market for international pharmaceutical companies , which are relying on growth in emerging markets to offset slower sales in @entity111 markets where many former blockbuster drugs have lost patent protection			1
@entity114 , which tracks pharmaceutical industry trends , expects @entity5 to overtake @entity116 as the world 's second - biggest drugs market behind the @entity119 by 2016 .			2

newspaper claims @entity16 firm used improper tactics to market procedure

@entity81:Russian
@entity16:British
@entity0:GSK
@entity5:China
@entity24:Wall Street Journal
@entity4:Botox
@entity18:Allergan
@entity80:World War II
@entity116:Japan
@entity114:IMS Health
@entity79:Vasily Zaytsev
@entity78:Vasily
@entity99:Changsha
@entity111:Western
@entity119:United States
@entity34:London